Yayın:
Design, synthesis and biological evaluation of new bis(thiosemicarbazone) derivatives as potential targeted anticancer agents for non-small cell lung cancer

dc.contributor.authorSEVER, BELGİN
dc.contributor.authorAKALIN ÇİFTÇİ, GÜLŞEN
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorMehlika Dilek Altıntop
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0001-9535-2508
dc.contributor.orcid0000-0003-0280-5550
dc.contributor.orcid0000-0002-8159-663X
dc.date.accessioned2025-11-13T12:18:11Z
dc.date.issued2020-09-11
dc.identifier.doihttps://doi.org/10.35333/jrp.2020.222
dc.identifier.endpage680
dc.identifier.issn2630-6344
dc.identifier.issue5
dc.identifier.openalexW3086530529
dc.identifier.startpage670
dc.identifier.urihttps://hdl.handle.net/11421/9605
dc.identifier.urihttps://doi.org/10.35333/jrp.2020.222
dc.identifier.volume24
dc.language.isoen
dc.relation.ispartofJournal of Research in Pharmacy
dc.rightsopenAccess
dc.subjectSemicarbazone
dc.subjectCancer
dc.subjectCell
dc.subjectCancer research
dc.subjectCombinatorial chemistry
dc.subjectChemistry
dc.subjectPharmacology
dc.subjectNanotechnology
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectStereochemistry
dc.subjectMaterials science
dc.subjectBiochemistry
dc.subject.sdg3
dc.titleDesign, synthesis and biological evaluation of new bis(thiosemicarbazone) derivatives as potential targeted anticancer agents for non-small cell lung cancer
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5040352588
local.authorid.openalexA5059753642
local.authorid.openalexA5048968214

Dosyalar

Koleksiyonlar